LAUREL BLYMYER: Open Payments
NPI 1124334750 · STERLING, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$676 in 30 payments from 11 companies in 2025. Trend: 2023 $735 · 2024 $795 · 2025 $676
Food & beverage: $676
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 16 | $375 |
| ABBVIE INC. | 3 | $74 |
| AstraZeneca Pharmaceuticals LP | 3 | $68 |
| Exact Sciences Corporation | 1 | $23 |
| Abbott Laboratories | 1 | $22 |
| ALK-Abello, Inc | 1 | $20 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $20 |
| Esperion Therapeutics, Inc. | 1 | $20 |
| Lilly USA, LLC | 1 | $18 |
| Dexcom, Inc. | 1 | $18 |
Products named: Wegovy, Rybelsus, Ozempic, UBRELVY, AIRSUPRA, QULIPTA, BREZTRI, The Cologuard Plus Collection Kit.
Industry payments across VA — which companies pay providers there.
